The Modern Urologist

Private Equity in Urology

November 18, 2019 Myriad Genetics Season 1 Episode 10
The Modern Urologist
Private Equity in Urology
Show Notes

Dr. Mike Gambla from Central Ohio Urology Group joins The Modern Urologist to talk about his experience with private equity acquisitions (PE) in the Urology space. The idea of potential culture disruptions and other pros and cons of PE acquisitions are discussed at length. Dr. Gambla offers his own insights to any independent practice considering an acquisition. The conversation changes to the role nurse navigators play in getting patients with advanced disease states better care through second and third line therapies. The need for analytics to improve patient outcomes and forecast practice needs are also discussed.